Suprajit Engineering – Honasa is among five selections of small and mid-cap stocks by Emkay Global with upside potential of up to 23%

Emkay Global has a buy rating on Metropolis Healthcare and a price target of Rs 2,200, a potential upside of 12.2%.

(Disclaimer: Recommendations, suggestions, views and opinions expressed by the experts are their own. These do not represent the views of Economic Times)